Belpointe PREP, LLC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Belpointe PREP, LLC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.19M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.68M | Mar 20, 2026 |
| FY2024 | Dec 31, 2023 | $2.25M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.39M | Sep 20, 2024 |
| FY2022 | Dec 31, 2021 | $997.0K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $101.0K | Mar 11, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($40.05M) | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | ($23.86M) | Mar 20, 2026 |
| FY2024 | Dec 31, 2023 | ($14.35M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($7.68M) | Sep 20, 2024 |
| FY2022 | Dec 31, 2021 | ($3.14M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($112.0K) | Mar 11, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($25.21M) | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | ($13.69M) | Mar 20, 2026 |
| FY2024 | Dec 31, 2023 | ($6.95M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($6.65M) | Sep 20, 2024 |
| FY2022 | Dec 31, 2021 | ($2.27M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($12.0K) | Mar 11, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $564.20M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | $517.59M | Mar 20, 2026 |
| FY2024 | Dec 31, 2023 | $382.12M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $354.00M | Sep 20, 2024 |
| FY2022 | Dec 31, 2021 | $341.43M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $37.28M | Mar 11, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $288.98M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | $213.53M | Mar 20, 2026 |
| FY2024 | Dec 31, 2023 | $57.05M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $21.34M | Sep 20, 2024 |
| FY2022 | Dec 31, 2021 | $17.55M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $37.38M | Mar 11, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.34M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | $24.74M | Mar 20, 2026 |
| FY2024 | Dec 31, 2023 | $20.13M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $143.47M | Sep 20, 2024 |
| FY2022 | Jun 28, 2022 | $87.0K | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $192.13M | Mar 31, 2023 |
| FY2022 | Nov 30, 2021 | $2.17M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $6.58M | Mar 11, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $260.64M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | $177.02M | Mar 20, 2026 |
| FY2024 | Dec 31, 2023 | $19.68M | Mar 31, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (10) | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | (6) | Mar 20, 2026 |
| FY2024 | Dec 31, 2023 | (4) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (2) | Sep 20, 2024 |
| FY2022 | Dec 31, 2021 | (7) | Mar 31, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (10) | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | (6) | Mar 20, 2026 |
| FY2024 | Dec 31, 2023 | (4) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (2) | Sep 20, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2021 | 1,190 | Mar 31, 2023 |